Some people with autism spectrum disorder (ASD) have abnormal levels of glutamate in the brain. New research led by Mass General Brigham has focused on this neuron-activating chemical, suggesting that a glutamate-modulating drug called memantine may improve social functioning in youth with ASD who do not have intellectual disabilities.
This article was originally published on MedicalXpress.com